NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/09/2025
Back to search
Official data from USPTO
ABZENA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ABZENA
ST13
US500000086234440Class
1, 5, 42, 44
Filing
86234440
Registration
4737716
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
09/10/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
03/27/2014
Registration date
05/19/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2025
Last transaction
09/10/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
24
Owner location
CAMBRIDGE, GB
Examiner
LOTT, MAUREEN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ABZENA (UK) LIMITED
PolyTherics Ltd.
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; chemicals for use in the pharmaceutical industryintermediates for pharmaceuticals; intermediates being chemicals for use in industrychemicals for use in the manufacture of pharmaceuticals
Class 5
Pharmaceuticalspharmaceutical compositionspharmaceutical preparationsused to treat cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; chemical preparations for medical or pharmaceutical purposeschemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; chemico-pharmaceutical preparationspharmaceutical preparations for the treatment of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection
Class 42
Scientific research and product development services in relation to pharmaceutical and medical products; scientific servicesproduct development in the field of pharmaceuticals; researchscientific research and product development in the field of pharmaceuticals; industrial research in the field of pharmaceuticals; product design in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals; provision of scientific information in the fields of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; providing of scientific information regarding pharmaceuticals and medicines; provision of scientific information relating to the chemical industryinformation on the subject of chemical product development
Class 44
Medical servicesproviding medical information regarding pharmaceuticals; pharmaceutical services and provision of pharmaceutical informationall in the nature of providing medical information regarding pharmaceuticals; providing to others a collection of informationproviding medical information relating to the use of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/09/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/09/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/19/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/21/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/21/2021
ES8R
TEAS SECTION 8 RECEIVED
05/18/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/19/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/31/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2015
PUBO
PUBLISHED FOR OPPOSITION
03/03/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/23/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
01/22/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/22/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
01/22/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/22/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2014
GNRT
NON-FINAL ACTION E-MAILED
12/15/2014
CNRT
NON-FINAL ACTION WRITTEN
12/15/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/24/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2014
ALIE
ASSIGNED TO LIE
11/24/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/28/2014
GNRT
NON-FINAL ACTION E-MAILED
06/28/2014
CNRT
NON-FINAL ACTION WRITTEN
06/28/2014
DOCK
ASSIGNED TO EXAMINER
06/28/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2014
NWAP
NEW APPLICATION ENTERED
03/31/2014
Continuous trademark protection
Get notified about every new filing that threatens ABZENA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.